Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Towa Creates New Division to More Promptly Supply Information Required by Users
May 14, 2007
- BUSINESS NEWS IN BRIEF
May 14, 2007
- DSP Aims at Annual Sales of \170 Mil. Per MR in FY2009
May 14, 2007
- Cancer Pain Killer Metastron Recommended for Approval
May 14, 2007
- Eplerenone, Topiramate, Rocuronium Recommended for Approval
May 14, 2007
- Substitute Products to Be Approved by Minor Change Notices
May 14, 2007
- REGULATORY NEWS IN BRIEF
May 14, 2007
- Shionogi Looks for Partner for Anti-Obesity Drug in PIII
May 14, 2007
- Safety of Crestor Confirmed in Japanese: AstraZeneca, Shionogi
May 14, 2007
- 5-Year Strategy to Develop Innovative Drugs, Med. Devices Proposed
May 14, 2007
- R&D NEWS IN BRIEF
May 14, 2007
- JSMI Announces 70 Candidates for Switch OTC Drugs
May 14, 2007
- Banyu Committed to Simultaneous Global Development
May 14, 2007
- Nihon Medi-Physics Completes Nationwide Distribution System for FDG
May 14, 2007
- GENERIC NEWS IN BRIEF
May 14, 2007
- Given Imaging to Launch Capsule Endoscope
May 14, 2007
- Kyowa Hakko Submits NDA for KW-6002 Combination Therapy for Parkinson's Disease in US
May 14, 2007
- MEDICAL DEVICE NEWS IN BRIEF
May 14, 2007
- Sales of Nicotinell Show 2.5-Fold Increase: Novartis
May 14, 2007
- Crestor, Drug of Choice for High-Risk Patients: Prof. Teramoto
May 14, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…